跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nasatapp - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nasatapp
Approved
STANDARD
Nasatapp
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
009342c013637c68
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
009342c013637c68
Drug Approval Philippines Name
Nasatapp
Product Name
Nasatapp
Registration Number
DR-XY24309
Brand Name
Nasatapp
Generic Name
Phenylpropanolamine Hydrochloride + Brompheniramine Maleate
Dosage Form
Syrup
Dosage Strength
12.5 mg/4 mg per 5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Nurturemed Pharma Inc.
Issuance Date
29 April 2023
Expiry Date
01 July 2028
Pharmacologic Category
Decongestant/Antihistamine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
009342c013637c68
Type
Standard
Back to Philippines FDA Approvals